Learn about who we are, what we believe
and the people who lead us
Discover our unique scientific approach
for diseases with high unmet need.
The first and only FDA-approved
treatment for Demodex blepharitis
Explore the possibilities of our robust pipeline
to address significant unmet patient needs
Find additional corporate
and stock information.
Ocular rosacea is a common inflammatory condition of the eye that impacts 15-18 million people in the United States1-3
The National Rosacea Society estimates that ocular rosacea may exist in up to 60% of patients with rosacea.4
Actual representation of ocular rosacea.
1. Macsai MS, Mannis MJ, Huntly AC. Chapter 41: Ocular rosacea. Published 1996. Accessed January 6, 2025. https://escholarship.org/content/qt2x84c8cp/rosacea.html 2. Dudee J, Ing EB (ed). Ocular rosacea. Updated March 13, 2024. Accessed January 6, 2025. https://emedicine.medscape.com/article/1197341-overview#showall 3. U.S. and world population clock. United States Census Bureau. Accessed January 6, 2025. https://www.census.gov/popclock/ 4. Ocular rosacea: what your eyes may be trying to tell you. National Rosacea Society. Published January 20, 2015. Accessed January 5, 2025. https://www.rosacea.org/blog/2015/january/ocular-rosacea-what-your-eyes-may-be-trying-to-tell-you 5. Akpek EK, Merchant A, Pinar V, Foster CS. Ocular rosacea patient characteristics and follow-up. Ophthalmology. 1997;104(11):1863-1867.
Our Terms of Use and Privacy Policy have changed.
By clicking accept, you agree that you have read and will abide by these new terms.